| Objective: To observe the effect of Qing-hua-tiao-wei-yin (QHTWY) onHelicobacter Pylori-associated superficial gastritis (HpASG) and explore the mechanism ofit.Methods:60patients with HpASG were divided into two groups at random: thetreatment group and the control group.The treatment group was given QHTWY, and thecontrol group was given omeprazole, metronidazole, amoxicillin．4weeks were set as acourse of treatment.The clinical effects of each group were observed during the course.Results: The treatment group in clinical symptom control rate (recovery rate+significant efficiency) is better than that of the control group (P<0.05), the total effectiverate in two groups non-significance difference (p>0.05). In the improvement of TCMsymptoms total score, the treatment group was better than control group (p<0.01). In theendoscopic observation and Hp-killing rate, two groups have non-significance difference(p>0.05).Conclusions: Qing-hua-tiao-wei-yin is a safe and effective drug of treating thesyndrome of Shire Zhongzu on Helicobacter Pylori-associated superficial gastritis. |
